11 results
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
in homeostatic functions of RPEs, including ameliorating lysosomal dysfunction and salvaging the ability of RPE cells to recycle photoreceptor outer segments
DRS
CGTX
Cognition Therapeutics Inc
20 Oct 22
Draft registration statement
12:00am
of RPE cells to recycle photoreceptor outer segments.
Confidential Treatment Requested by Cognition Therapeutics, Inc.
Pursuant to 17 C.F.R. Section
10-K
2021 FY
CGTX
Cognition Therapeutics Inc
30 Mar 22
Annual report
7:40am
functions of RPEs, including ameliorating lysosomal dysfunction and salvaging the ability of RPE cells to recycle photoreceptor outer segments.
Table
424B4
g5sig2ln9egv 48
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
7rbfb
19 Jul 21
IPO registration
7:02am
DRS/A
8cxes45kjn1gdzdgxwlq
23 Jun 21
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next